Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303

Press/Media

Period	17 Dec 2018

Media coverage

Title	Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303
Media name/outlet	Spoke.com
Country/Territory	United States
Date	17/12/18
URL	www.spoke.com/press_releases/5c175f902cf3f7f6cb03bec2
Persons	Jeremiah Faith